' Ozempic Ftw: ' Elon Musk Touts Novo Nordisk ' s Blockbuster Drug As Solution To Childhood Obesity Problem

Tesla and SpaceX CEO Elon Musk has sparked a conversation about childhood obesity and potential solutions after giving his seal of approval for Novo Nordisk‘s NVO Ozempic, a GLP-1 agonist primarily prescribed to manage Type 2 diabetes. What Happened: On Sunday, Musk responded to a post on X about…#tesla #elonmusk #glp1 #calleymeans #billackman #donaldtrump #robertkennedyjr #apple #walmart #novonordisk
Source: Reuters: Health - Category: Consumer Health News Source Type: news